InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Wednesday, 05/20/2015 10:22:01 AM

Wednesday, May 20, 2015 10:22:01 AM

Post# of 80868
I don't see that the financing of the company should be such a big issue.

First of all, we have been told that Musclepharm is working on converting it's local bank loan to a commercial bank loan. A bank loan that is of moderate size considering the size of it's operations.

Furtheremore, the board and the management could always substitute the employee stock purchase plan with a capital raise of equal size instead...

The employee stock purchase plan is nothing else than a capital raising mechanism, spread over many years versus being a one time event. The dilution would be unchanged if there is a substitution of one type of capital raise with another.

Musclepharm kind of needs a higher stock price, and the employee stock purchase plan is already factored into the stock price, so it is really a non-brainer.